International Conference on Nephrology and Genetic Kidney Disorders (ICNGKD - 26)

The International Conference on Nephrology and Genetic Kidney Disorders (ICNGKD-26) is a two-day hybrid international conference organized by Science Net, scheduled for October 9–10, 2026. The conference brings together nephrologists, medical geneticists, physicians, researchers, scientists, and other healthcare professionals to discuss emerging developments in genetic and inherited kidney disorders and their implications for diagnosis, treatment, and patient care. The conference places significant emphasis on advancements in genetic testing for kidney disorders. Participants will examine the applications and challenges of next-generation sequencing (NGS) in identifying genetic variants associated with renal disease. The programme also explores emerging biomarkers that may support earlier detection and monitoring, as well as the use of pharmacogenomics to help tailor treatments according to individual genetic profiles. Another major focus is the molecular pathophysiology of genetic kidney disease. Sessions examine gene-environment interactions, cellular and molecular pathways involved in renal damage, and the role of epigenetic modifications in the development and progression of nephropathies. These discussions provide a scientific foundation for understanding how genetic and environmental factors contribute to kidney disease. The programme also addresses inherited kidney diseases from a clinical perspective. Particular attention is given to polycystic kidney disease, including both autosomal dominant and autosomal recessive forms, as well as Alport syndrome and collagen IV nephropathies. The conference additionally considers rare genetic kidney disorders through clinical cases and discussions of current management strategies. Innovations in renal health management form another component of the programme. Participants will explore emerging therapeutic approaches, including gene therapy, gene editing, and targeted molecular treatments. The conference also examines telemedicine and digital health technologies as tools for improving access to nephrology services and supporting patients with complex genetic kidney conditions. The programme places importance on patient-centered care, recognizing that genetic kidney disorders can affect not only individual patients but also their families. Participants will consider integrated care models designed to address complex medical, genetic, psychosocial, and family needs. The conference further explores the ethical, legal, and social dimensions of genetic testing. Topics include genetic counseling, communication of genetic risk and test results, protection of genetic information, data privacy and security, and equitable access to genetic testing and advanced therapies. In addition to its scientific programme, ICNGKD-26 provides opportunities for research presentations, international networking, interdisciplinary collaboration, and knowledge exchange. Submitted abstracts and full papers are subject to peer review, with opportunities for accepted research to be considered for journal publication. Overall, ICNGKD-26 provides a multidisciplinary platform for examining the intersection of nephrology, medical genetics, molecular biology, clinical medicine, and emerging renal therapies, with an emphasis on translating genetic and scientific discoveries into improved diagnosis, treatment, and patient-centered care.